Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Albireo Pharma Inc (NQ: ALBO )

37.68 USD +1.30 (+3.57%)
Streaming Delayed Price Updated: 1:35 PM EST, Jan 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Albireo Pharma Inc

< Previous 1 2 3 4 5 6 7 8 9 Next >
Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat
From GlobeNewswire News Releases
Albireo Recognizes International Alagille Syndrome Awareness Day 2021
Albireo supports the Alagille syndrome community to advocate for more education and new treatment advances for rare cholestatic liver diseases 
From GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Albireo to Host Virtual Investor Commercial Day 2021
From GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Albireo to Participate in H.C. Wainwright BioConnect and LifeSci Advisors Investor Conferences
From GlobeNewswire News Releases
Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome
From GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
Albireo Submits for U.S. FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC
From GlobeNewswire News Releases
How The Parts Add Up: DWAS Headed For $77
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
Biotech stocks advanced in the week ended Nov. 13 amid a vaccine news flow-induced rally that also lifted the broader market. The ... 
Tags LCTX Benzinga JAGX
From Benzinga
New Phase 3 Data at AASLD Show Durable Response to Odevixibat in a Rare Pediatric Liver Disease
From GlobeNewswire News Releases
Albireo to Participate in Jefferies and Piper Sandler Virtual Investor Conferences
From GlobeNewswire News Releases
Albireo Reports Q3 2020 Financial Results and Provides Business Update
From GlobeNewswire News Releases
Albireo’s Odevixibat PFIC Phase 3 Results Accepted for AASLD Late-Breakers
From GlobeNewswire News Releases
Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting
From GlobeNewswire News Releases
Cramer Gives His Opinion On Cloudera, Barrick Gold And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said Zuora Inc (NYSE: ZUO) is struggling because it has real ... 
Tags Media ALBO TMO
From Benzinga
IEIH's Holdings Imply 17% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Albireo Recognizes PFIC Awareness Day 2020
Albireo stands together with the PFIC community to highlight critical need for education and advances in research for rare cholestatic liver diseases 
From GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From GlobeNewswire News Releases
First Week of November 20th Options Trading For Albireo Pharma
Investors in Albireo Pharma Inc (ALBO) saw new options begin trading this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALBO... 
Tags Stocks
From Market News Video
Notable Insider Buys of the Past Week: Nikola, Transdigm And More
Insider buying can be an encouraging signal for potential investors when markets are near all-time highs. One ... 
Tags Insider Trades CRY Alcoa
From Benzinga
Insider Buys Albireo Pharma's Shares
Perceptive Advisors Llc filed a Form 4 with the SEC on Tuesday, September 15. The insider bought 400,000 shares of Albireo Pharma Inc ... 
Tags Benzinga Insider Trade ALBO
From Benzinga
Investors Land ALBO Even Cheaper Than Its Secondary Stock Offering
Looking back to 2 days ago, Albireo Pharma Inc (ALBO) priced a 4,000,000 share secondary stock offering at $40.00 per share. Buyers in that offering made a considerable investment into the company,... 
Tags Stocks
From Market News Video
Albireo Prices Public Offering of 4,000,000 Shares of Common Stock
From GlobeNewswire News Releases
44 Stocks Moving in Wednesday's Pre-Market Session
Gainers Superconductor Technologies Inc (NASDAQ: SCON) rose 45.8% to $0.35 in pre-market trading after declining 7% on Tuesday. ... 
Tags SCON CHEK SRG
From Benzinga
64 Biggest Movers From Yesterday
Gainers Luby's, Inc. (NYSE: LUB) rose 111.4% to close at $2.22 on Tuesday. Luby's board adopted plan of liquidation and ... 
Tags IBEX Markets FTSI
From Benzinga
Albireo Pharma Joins Elite Club Of Stocks With RS Ratings Over 90
Albireo Pharma sees its Relative Strength Rating reach the elite 90-plus level. 
From Investor's Business Daily
Albireo Announces Proposed Public Offering of 3,000,000 Shares of Common Stock
From GlobeNewswire News Releases
Mid-Afternoon Market Update: Dow Falls 1.5%; Nikola Shares Surge
Toward the end of trading Tuesday, the Dow traded down 1.54% to 27699.01 while the NASDAQ fell 3.06% to 10967.25. The S&P also fell, ... 
Tags Global CODX Benzinga
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X